Global Recombinant Follicle Stimulating Hormone Supply, Demand and Key Producers, 2024-2030

Global Recombinant Follicle Stimulating Hormone Supply, Demand and Key Producers, 2024-2030

Page: 102

Published Date: 19 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Recombinant Follicle Stimulating Hormone market size is expected to reach $ 1550.5 million by 2030, rising at a market growth of 5.4% CAGR during the forecast period (2024-2030).

Recombinant FSH is produced through recombinant DNA technology. These products are pure and do not contain the "contaminants" seen in urine extraction FSH. It is given subcutaneously with much less discomfort. Both human and genetically derived products are difficult to obtain and manufacture and are therefore expensive.

This report studies the global Recombinant Follicle Stimulating Hormone production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Follicle Stimulating Hormone, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Follicle Stimulating Hormone that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Recombinant Follicle Stimulating Hormone total production and demand, 2019-2030, (K Doses)
Global Recombinant Follicle Stimulating Hormone total production value, 2019-2030, (USD Million)
Global Recombinant Follicle Stimulating Hormone production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Doses)
Global Recombinant Follicle Stimulating Hormone consumption by region & country, CAGR, 2019-2030 & (K Doses)
U.S. VS China: Recombinant Follicle Stimulating Hormone domestic production, consumption, key domestic manufacturers and share
Global Recombinant Follicle Stimulating Hormone production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Doses)
Global Recombinant Follicle Stimulating Hormone production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Doses)
Global Recombinant Follicle Stimulating Hormone production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Doses).

This reports profiles key players in the global Recombinant Follicle Stimulating Hormone market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Serono, MSD, Techwell, GenSci, Gedeon Richter and Teva, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Follicle Stimulating Hormone market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (USD/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Recombinant Follicle Stimulating Hormone Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Recombinant Follicle Stimulating Hormone Market, Segmentation by Type
75IU
150IU
Others

Global Recombinant Follicle Stimulating Hormone Market, Segmentation by Application
Infertility Treatment
Assisted Reproductive Technology

Companies Profiled:
Merck Serono
MSD
Techwell
GenSci
Gedeon Richter
Teva

Key Questions Answered
1. How big is the global Recombinant Follicle Stimulating Hormone market?
2. What is the demand of the global Recombinant Follicle Stimulating Hormone market?
3. What is the year over year growth of the global Recombinant Follicle Stimulating Hormone market?
4. What is the production and production value of the global Recombinant Follicle Stimulating Hormone market?
5. Who are the key producers in the global Recombinant Follicle Stimulating Hormone market?
btl

Table of Contents

1 Supply Summary
1.1 Recombinant Follicle Stimulating Hormone Introduction
1.2 World Recombinant Follicle Stimulating Hormone Supply & Forecast
1.2.1 World Recombinant Follicle Stimulating Hormone Production Value (2019 & 2023 & 2030)
1.2.2 World Recombinant Follicle Stimulating Hormone Production (2019-2030)
1.2.3 World Recombinant Follicle Stimulating Hormone Pricing Trends (2019-2030)
1.3 World Recombinant Follicle Stimulating Hormone Production by Region (Based on Production Site)
1.3.1 World Recombinant Follicle Stimulating Hormone Production Value by Region (2019-2030)
1.3.2 World Recombinant Follicle Stimulating Hormone Production by Region (2019-2030)
1.3.3 World Recombinant Follicle Stimulating Hormone Average Price by Region (2019-2030)
1.3.4 North America Recombinant Follicle Stimulating Hormone Production (2019-2030)
1.3.5 Europe Recombinant Follicle Stimulating Hormone Production (2019-2030)
1.3.6 China Recombinant Follicle Stimulating Hormone Production (2019-2030)
1.3.7 Japan Recombinant Follicle Stimulating Hormone Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Follicle Stimulating Hormone Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Follicle Stimulating Hormone Major Market Trends

2 Demand Summary
2.1 World Recombinant Follicle Stimulating Hormone Demand (2019-2030)
2.2 World Recombinant Follicle Stimulating Hormone Consumption by Region
2.2.1 World Recombinant Follicle Stimulating Hormone Consumption by Region (2019-2024)
2.2.2 World Recombinant Follicle Stimulating Hormone Consumption Forecast by Region (2025-2030)
2.3 United States Recombinant Follicle Stimulating Hormone Consumption (2019-2030)
2.4 China Recombinant Follicle Stimulating Hormone Consumption (2019-2030)
2.5 Europe Recombinant Follicle Stimulating Hormone Consumption (2019-2030)
2.6 Japan Recombinant Follicle Stimulating Hormone Consumption (2019-2030)
2.7 South Korea Recombinant Follicle Stimulating Hormone Consumption (2019-2030)
2.8 ASEAN Recombinant Follicle Stimulating Hormone Consumption (2019-2030)
2.9 India Recombinant Follicle Stimulating Hormone Consumption (2019-2030)

3 World Recombinant Follicle Stimulating Hormone Manufacturers Competitive Analysis
3.1 World Recombinant Follicle Stimulating Hormone Production Value by Manufacturer (2019-2024)
3.2 World Recombinant Follicle Stimulating Hormone Production by Manufacturer (2019-2024)
3.3 World Recombinant Follicle Stimulating Hormone Average Price by Manufacturer (2019-2024)
3.4 Recombinant Follicle Stimulating Hormone Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Follicle Stimulating Hormone Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Follicle Stimulating Hormone in 2023
3.5.3 Global Concentration Ratios (CR8) for Recombinant Follicle Stimulating Hormone in 2023
3.6 Recombinant Follicle Stimulating Hormone Market: Overall Company Footprint Analysis
3.6.1 Recombinant Follicle Stimulating Hormone Market: Region Footprint
3.6.2 Recombinant Follicle Stimulating Hormone Market: Company Product Type Footprint
3.6.3 Recombinant Follicle Stimulating Hormone Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Recombinant Follicle Stimulating Hormone Production Value Comparison
4.1.1 United States VS China: Recombinant Follicle Stimulating Hormone Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Recombinant Follicle Stimulating Hormone Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Recombinant Follicle Stimulating Hormone Production Comparison
4.2.1 United States VS China: Recombinant Follicle Stimulating Hormone Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Recombinant Follicle Stimulating Hormone Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Recombinant Follicle Stimulating Hormone Consumption Comparison
4.3.1 United States VS China: Recombinant Follicle Stimulating Hormone Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Recombinant Follicle Stimulating Hormone Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Recombinant Follicle Stimulating Hormone Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Recombinant Follicle Stimulating Hormone Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value (2019-2024)
4.4.3 United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production (2019-2024)
4.5 China Based Recombinant Follicle Stimulating Hormone Manufacturers and Market Share
4.5.1 China Based Recombinant Follicle Stimulating Hormone Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value (2019-2024)
4.5.3 China Based Manufacturers Recombinant Follicle Stimulating Hormone Production (2019-2024)
4.6 Rest of World Based Recombinant Follicle Stimulating Hormone Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Recombinant Follicle Stimulating Hormone Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production (2019-2024)

5 Market Analysis by Type
5.1 World Recombinant Follicle Stimulating Hormone Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 75IU
5.2.2 150IU
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Recombinant Follicle Stimulating Hormone Production by Type (2019-2030)
5.3.2 World Recombinant Follicle Stimulating Hormone Production Value by Type (2019-2030)
5.3.3 World Recombinant Follicle Stimulating Hormone Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Recombinant Follicle Stimulating Hormone Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Infertility Treatment
6.2.2 Assisted Reproductive Technology
6.3 Market Segment by Application
6.3.1 World Recombinant Follicle Stimulating Hormone Production by Application (2019-2030)
6.3.2 World Recombinant Follicle Stimulating Hormone Production Value by Application (2019-2030)
6.3.3 World Recombinant Follicle Stimulating Hormone Average Price by Application (2019-2030)

7 Company Profiles
7.1 Merck Serono
7.1.1 Merck Serono Details
7.1.2 Merck Serono Major Business
7.1.3 Merck Serono Recombinant Follicle Stimulating Hormone Product and Services
7.1.4 Merck Serono Recombinant Follicle Stimulating Hormone Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Merck Serono Recent Developments/Updates
7.1.6 Merck Serono Competitive Strengths & Weaknesses
7.2 MSD
7.2.1 MSD Details
7.2.2 MSD Major Business
7.2.3 MSD Recombinant Follicle Stimulating Hormone Product and Services
7.2.4 MSD Recombinant Follicle Stimulating Hormone Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 MSD Recent Developments/Updates
7.2.6 MSD Competitive Strengths & Weaknesses
7.3 Techwell
7.3.1 Techwell Details
7.3.2 Techwell Major Business
7.3.3 Techwell Recombinant Follicle Stimulating Hormone Product and Services
7.3.4 Techwell Recombinant Follicle Stimulating Hormone Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Techwell Recent Developments/Updates
7.3.6 Techwell Competitive Strengths & Weaknesses
7.4 GenSci
7.4.1 GenSci Details
7.4.2 GenSci Major Business
7.4.3 GenSci Recombinant Follicle Stimulating Hormone Product and Services
7.4.4 GenSci Recombinant Follicle Stimulating Hormone Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 GenSci Recent Developments/Updates
7.4.6 GenSci Competitive Strengths & Weaknesses
7.5 Gedeon Richter
7.5.1 Gedeon Richter Details
7.5.2 Gedeon Richter Major Business
7.5.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Product and Services
7.5.4 Gedeon Richter Recombinant Follicle Stimulating Hormone Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Gedeon Richter Recent Developments/Updates
7.5.6 Gedeon Richter Competitive Strengths & Weaknesses
7.6 Teva
7.6.1 Teva Details
7.6.2 Teva Major Business
7.6.3 Teva Recombinant Follicle Stimulating Hormone Product and Services
7.6.4 Teva Recombinant Follicle Stimulating Hormone Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Teva Recent Developments/Updates
7.6.6 Teva Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Recombinant Follicle Stimulating Hormone Industry Chain
8.2 Recombinant Follicle Stimulating Hormone Upstream Analysis
8.2.1 Recombinant Follicle Stimulating Hormone Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Follicle Stimulating Hormone Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Follicle Stimulating Hormone Production Mode
8.6 Recombinant Follicle Stimulating Hormone Procurement Model
8.7 Recombinant Follicle Stimulating Hormone Industry Sales Model and Sales Channels
8.7.1 Recombinant Follicle Stimulating Hormone Sales Model
8.7.2 Recombinant Follicle Stimulating Hormone Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Recombinant Follicle Stimulating Hormone Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Recombinant Follicle Stimulating Hormone Production Value by Region (2019-2024) & (USD Million)
Table 3. World Recombinant Follicle Stimulating Hormone Production Value by Region (2025-2030) & (USD Million)
Table 4. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Region (2019-2024)
Table 5. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Region (2025-2030)
Table 6. World Recombinant Follicle Stimulating Hormone Production by Region (2019-2024) & (K Doses)
Table 7. World Recombinant Follicle Stimulating Hormone Production by Region (2025-2030) & (K Doses)
Table 8. World Recombinant Follicle Stimulating Hormone Production Market Share by Region (2019-2024)
Table 9. World Recombinant Follicle Stimulating Hormone Production Market Share by Region (2025-2030)
Table 10. World Recombinant Follicle Stimulating Hormone Average Price by Region (2019-2024) & (USD/Dose)
Table 11. World Recombinant Follicle Stimulating Hormone Average Price by Region (2025-2030) & (USD/Dose)
Table 12. Recombinant Follicle Stimulating Hormone Major Market Trends
Table 13. World Recombinant Follicle Stimulating Hormone Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Doses)
Table 14. World Recombinant Follicle Stimulating Hormone Consumption by Region (2019-2024) & (K Doses)
Table 15. World Recombinant Follicle Stimulating Hormone Consumption Forecast by Region (2025-2030) & (K Doses)
Table 16. World Recombinant Follicle Stimulating Hormone Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Follicle Stimulating Hormone Producers in 2023
Table 18. World Recombinant Follicle Stimulating Hormone Production by Manufacturer (2019-2024) & (K Doses)
Table 19. Production Market Share of Key Recombinant Follicle Stimulating Hormone Producers in 2023
Table 20. World Recombinant Follicle Stimulating Hormone Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 21. Global Recombinant Follicle Stimulating Hormone Company Evaluation Quadrant
Table 22. World Recombinant Follicle Stimulating Hormone Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Recombinant Follicle Stimulating Hormone Production Site of Key Manufacturer
Table 24. Recombinant Follicle Stimulating Hormone Market: Company Product Type Footprint
Table 25. Recombinant Follicle Stimulating Hormone Market: Company Product Application Footprint
Table 26. Recombinant Follicle Stimulating Hormone Competitive Factors
Table 27. Recombinant Follicle Stimulating Hormone New Entrant and Capacity Expansion Plans
Table 28. Recombinant Follicle Stimulating Hormone Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Follicle Stimulating Hormone Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Recombinant Follicle Stimulating Hormone Production Comparison, (2019 & 2023 & 2030) & (K Doses)
Table 31. United States VS China Recombinant Follicle Stimulating Hormone Consumption Comparison, (2019 & 2023 & 2030) & (K Doses)
Table 32. United States Based Recombinant Follicle Stimulating Hormone Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production (2019-2024) & (K Doses)
Table 36. United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production Market Share (2019-2024)
Table 37. China Based Recombinant Follicle Stimulating Hormone Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Recombinant Follicle Stimulating Hormone Production (2019-2024) & (K Doses)
Table 41. China Based Manufacturers Recombinant Follicle Stimulating Hormone Production Market Share (2019-2024)
Table 42. Rest of World Based Recombinant Follicle Stimulating Hormone Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production (2019-2024) & (K Doses)
Table 46. Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production Market Share (2019-2024)
Table 47. World Recombinant Follicle Stimulating Hormone Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Recombinant Follicle Stimulating Hormone Production by Type (2019-2024) & (K Doses)
Table 49. World Recombinant Follicle Stimulating Hormone Production by Type (2025-2030) & (K Doses)
Table 50. World Recombinant Follicle Stimulating Hormone Production Value by Type (2019-2024) & (USD Million)
Table 51. World Recombinant Follicle Stimulating Hormone Production Value by Type (2025-2030) & (USD Million)
Table 52. World Recombinant Follicle Stimulating Hormone Average Price by Type (2019-2024) & (USD/Dose)
Table 53. World Recombinant Follicle Stimulating Hormone Average Price by Type (2025-2030) & (USD/Dose)
Table 54. World Recombinant Follicle Stimulating Hormone Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Recombinant Follicle Stimulating Hormone Production by Application (2019-2024) & (K Doses)
Table 56. World Recombinant Follicle Stimulating Hormone Production by Application (2025-2030) & (K Doses)
Table 57. World Recombinant Follicle Stimulating Hormone Production Value by Application (2019-2024) & (USD Million)
Table 58. World Recombinant Follicle Stimulating Hormone Production Value by Application (2025-2030) & (USD Million)
Table 59. World Recombinant Follicle Stimulating Hormone Average Price by Application (2019-2024) & (USD/Dose)
Table 60. World Recombinant Follicle Stimulating Hormone Average Price by Application (2025-2030) & (USD/Dose)
Table 61. Merck Serono Basic Information, Manufacturing Base and Competitors
Table 62. Merck Serono Major Business
Table 63. Merck Serono Recombinant Follicle Stimulating Hormone Product and Services
Table 64. Merck Serono Recombinant Follicle Stimulating Hormone Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Merck Serono Recent Developments/Updates
Table 66. Merck Serono Competitive Strengths & Weaknesses
Table 67. MSD Basic Information, Manufacturing Base and Competitors
Table 68. MSD Major Business
Table 69. MSD Recombinant Follicle Stimulating Hormone Product and Services
Table 70. MSD Recombinant Follicle Stimulating Hormone Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. MSD Recent Developments/Updates
Table 72. MSD Competitive Strengths & Weaknesses
Table 73. Techwell Basic Information, Manufacturing Base and Competitors
Table 74. Techwell Major Business
Table 75. Techwell Recombinant Follicle Stimulating Hormone Product and Services
Table 76. Techwell Recombinant Follicle Stimulating Hormone Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Techwell Recent Developments/Updates
Table 78. Techwell Competitive Strengths & Weaknesses
Table 79. GenSci Basic Information, Manufacturing Base and Competitors
Table 80. GenSci Major Business
Table 81. GenSci Recombinant Follicle Stimulating Hormone Product and Services
Table 82. GenSci Recombinant Follicle Stimulating Hormone Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. GenSci Recent Developments/Updates
Table 84. GenSci Competitive Strengths & Weaknesses
Table 85. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 86. Gedeon Richter Major Business
Table 87. Gedeon Richter Recombinant Follicle Stimulating Hormone Product and Services
Table 88. Gedeon Richter Recombinant Follicle Stimulating Hormone Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Gedeon Richter Recent Developments/Updates
Table 90. Teva Basic Information, Manufacturing Base and Competitors
Table 91. Teva Major Business
Table 92. Teva Recombinant Follicle Stimulating Hormone Product and Services
Table 93. Teva Recombinant Follicle Stimulating Hormone Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Global Key Players of Recombinant Follicle Stimulating Hormone Upstream (Raw Materials)
Table 95. Recombinant Follicle Stimulating Hormone Typical Customers
Table 96. Recombinant Follicle Stimulating Hormone Typical Distributors
List of Figure
Figure 1. Recombinant Follicle Stimulating Hormone Picture
Figure 2. World Recombinant Follicle Stimulating Hormone Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Recombinant Follicle Stimulating Hormone Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Recombinant Follicle Stimulating Hormone Production (2019-2030) & (K Doses)
Figure 5. World Recombinant Follicle Stimulating Hormone Average Price (2019-2030) & (USD/Dose)
Figure 6. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Region (2019-2030)
Figure 7. World Recombinant Follicle Stimulating Hormone Production Market Share by Region (2019-2030)
Figure 8. North America Recombinant Follicle Stimulating Hormone Production (2019-2030) & (K Doses)
Figure 9. Europe Recombinant Follicle Stimulating Hormone Production (2019-2030) & (K Doses)
Figure 10. China Recombinant Follicle Stimulating Hormone Production (2019-2030) & (K Doses)
Figure 11. Japan Recombinant Follicle Stimulating Hormone Production (2019-2030) & (K Doses)
Figure 12. Recombinant Follicle Stimulating Hormone Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 15. World Recombinant Follicle Stimulating Hormone Consumption Market Share by Region (2019-2030)
Figure 16. United States Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 17. China Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 18. Europe Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 19. Japan Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 20. South Korea Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 21. ASEAN Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 22. India Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 23. Producer Shipments of Recombinant Follicle Stimulating Hormone by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Follicle Stimulating Hormone Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Follicle Stimulating Hormone Markets in 2023
Figure 26. United States VS China: Recombinant Follicle Stimulating Hormone Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Recombinant Follicle Stimulating Hormone Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Recombinant Follicle Stimulating Hormone Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production Market Share 2023
Figure 30. China Based Manufacturers Recombinant Follicle Stimulating Hormone Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production Market Share 2023
Figure 32. World Recombinant Follicle Stimulating Hormone Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Type in 2023
Figure 34. 75IU
Figure 35. 150IU
Figure 36. Others
Figure 37. World Recombinant Follicle Stimulating Hormone Production Market Share by Type (2019-2030)
Figure 38. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Type (2019-2030)
Figure 39. World Recombinant Follicle Stimulating Hormone Average Price by Type (2019-2030) & (USD/Dose)
Figure 40. World Recombinant Follicle Stimulating Hormone Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Application in 2023
Figure 42. Infertility Treatment
Figure 43. Assisted Reproductive Technology
Figure 44. World Recombinant Follicle Stimulating Hormone Production Market Share by Application (2019-2030)
Figure 45. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Application (2019-2030)
Figure 46. World Recombinant Follicle Stimulating Hormone Average Price by Application (2019-2030) & (USD/Dose)
Figure 47. Recombinant Follicle Stimulating Hormone Industry Chain
Figure 48. Recombinant Follicle Stimulating Hormone Procurement Model
Figure 49. Recombinant Follicle Stimulating Hormone Sales Model
Figure 50. Recombinant Follicle Stimulating Hormone Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Merck Serono
MSD
Techwell
GenSci
Gedeon Richter
Teva
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Recombinant Follicle Stimulating Hormone Supply, Demand and Key Producers, 2024-2030

Global Recombinant Follicle Stimulating Hormone Supply, Demand and Key Producers, 2024-2030

Page: 102

Published Date: 19 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Recombinant Follicle Stimulating Hormone market size is expected to reach $ 1550.5 million by 2030, rising at a market growth of 5.4% CAGR during the forecast period (2024-2030).

Recombinant FSH is produced through recombinant DNA technology. These products are pure and do not contain the "contaminants" seen in urine extraction FSH. It is given subcutaneously with much less discomfort. Both human and genetically derived products are difficult to obtain and manufacture and are therefore expensive.

This report studies the global Recombinant Follicle Stimulating Hormone production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Follicle Stimulating Hormone, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Follicle Stimulating Hormone that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Recombinant Follicle Stimulating Hormone total production and demand, 2019-2030, (K Doses)
Global Recombinant Follicle Stimulating Hormone total production value, 2019-2030, (USD Million)
Global Recombinant Follicle Stimulating Hormone production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Doses)
Global Recombinant Follicle Stimulating Hormone consumption by region & country, CAGR, 2019-2030 & (K Doses)
U.S. VS China: Recombinant Follicle Stimulating Hormone domestic production, consumption, key domestic manufacturers and share
Global Recombinant Follicle Stimulating Hormone production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Doses)
Global Recombinant Follicle Stimulating Hormone production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Doses)
Global Recombinant Follicle Stimulating Hormone production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Doses).

This reports profiles key players in the global Recombinant Follicle Stimulating Hormone market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Serono, MSD, Techwell, GenSci, Gedeon Richter and Teva, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Follicle Stimulating Hormone market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (USD/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Recombinant Follicle Stimulating Hormone Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Recombinant Follicle Stimulating Hormone Market, Segmentation by Type
75IU
150IU
Others

Global Recombinant Follicle Stimulating Hormone Market, Segmentation by Application
Infertility Treatment
Assisted Reproductive Technology

Companies Profiled:
Merck Serono
MSD
Techwell
GenSci
Gedeon Richter
Teva

Key Questions Answered
1. How big is the global Recombinant Follicle Stimulating Hormone market?
2. What is the demand of the global Recombinant Follicle Stimulating Hormone market?
3. What is the year over year growth of the global Recombinant Follicle Stimulating Hormone market?
4. What is the production and production value of the global Recombinant Follicle Stimulating Hormone market?
5. Who are the key producers in the global Recombinant Follicle Stimulating Hormone market?
btl

Table of Contents

1 Supply Summary
1.1 Recombinant Follicle Stimulating Hormone Introduction
1.2 World Recombinant Follicle Stimulating Hormone Supply & Forecast
1.2.1 World Recombinant Follicle Stimulating Hormone Production Value (2019 & 2023 & 2030)
1.2.2 World Recombinant Follicle Stimulating Hormone Production (2019-2030)
1.2.3 World Recombinant Follicle Stimulating Hormone Pricing Trends (2019-2030)
1.3 World Recombinant Follicle Stimulating Hormone Production by Region (Based on Production Site)
1.3.1 World Recombinant Follicle Stimulating Hormone Production Value by Region (2019-2030)
1.3.2 World Recombinant Follicle Stimulating Hormone Production by Region (2019-2030)
1.3.3 World Recombinant Follicle Stimulating Hormone Average Price by Region (2019-2030)
1.3.4 North America Recombinant Follicle Stimulating Hormone Production (2019-2030)
1.3.5 Europe Recombinant Follicle Stimulating Hormone Production (2019-2030)
1.3.6 China Recombinant Follicle Stimulating Hormone Production (2019-2030)
1.3.7 Japan Recombinant Follicle Stimulating Hormone Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Follicle Stimulating Hormone Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Follicle Stimulating Hormone Major Market Trends

2 Demand Summary
2.1 World Recombinant Follicle Stimulating Hormone Demand (2019-2030)
2.2 World Recombinant Follicle Stimulating Hormone Consumption by Region
2.2.1 World Recombinant Follicle Stimulating Hormone Consumption by Region (2019-2024)
2.2.2 World Recombinant Follicle Stimulating Hormone Consumption Forecast by Region (2025-2030)
2.3 United States Recombinant Follicle Stimulating Hormone Consumption (2019-2030)
2.4 China Recombinant Follicle Stimulating Hormone Consumption (2019-2030)
2.5 Europe Recombinant Follicle Stimulating Hormone Consumption (2019-2030)
2.6 Japan Recombinant Follicle Stimulating Hormone Consumption (2019-2030)
2.7 South Korea Recombinant Follicle Stimulating Hormone Consumption (2019-2030)
2.8 ASEAN Recombinant Follicle Stimulating Hormone Consumption (2019-2030)
2.9 India Recombinant Follicle Stimulating Hormone Consumption (2019-2030)

3 World Recombinant Follicle Stimulating Hormone Manufacturers Competitive Analysis
3.1 World Recombinant Follicle Stimulating Hormone Production Value by Manufacturer (2019-2024)
3.2 World Recombinant Follicle Stimulating Hormone Production by Manufacturer (2019-2024)
3.3 World Recombinant Follicle Stimulating Hormone Average Price by Manufacturer (2019-2024)
3.4 Recombinant Follicle Stimulating Hormone Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Follicle Stimulating Hormone Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Follicle Stimulating Hormone in 2023
3.5.3 Global Concentration Ratios (CR8) for Recombinant Follicle Stimulating Hormone in 2023
3.6 Recombinant Follicle Stimulating Hormone Market: Overall Company Footprint Analysis
3.6.1 Recombinant Follicle Stimulating Hormone Market: Region Footprint
3.6.2 Recombinant Follicle Stimulating Hormone Market: Company Product Type Footprint
3.6.3 Recombinant Follicle Stimulating Hormone Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Recombinant Follicle Stimulating Hormone Production Value Comparison
4.1.1 United States VS China: Recombinant Follicle Stimulating Hormone Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Recombinant Follicle Stimulating Hormone Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Recombinant Follicle Stimulating Hormone Production Comparison
4.2.1 United States VS China: Recombinant Follicle Stimulating Hormone Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Recombinant Follicle Stimulating Hormone Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Recombinant Follicle Stimulating Hormone Consumption Comparison
4.3.1 United States VS China: Recombinant Follicle Stimulating Hormone Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Recombinant Follicle Stimulating Hormone Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Recombinant Follicle Stimulating Hormone Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Recombinant Follicle Stimulating Hormone Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value (2019-2024)
4.4.3 United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production (2019-2024)
4.5 China Based Recombinant Follicle Stimulating Hormone Manufacturers and Market Share
4.5.1 China Based Recombinant Follicle Stimulating Hormone Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value (2019-2024)
4.5.3 China Based Manufacturers Recombinant Follicle Stimulating Hormone Production (2019-2024)
4.6 Rest of World Based Recombinant Follicle Stimulating Hormone Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Recombinant Follicle Stimulating Hormone Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production (2019-2024)

5 Market Analysis by Type
5.1 World Recombinant Follicle Stimulating Hormone Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 75IU
5.2.2 150IU
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Recombinant Follicle Stimulating Hormone Production by Type (2019-2030)
5.3.2 World Recombinant Follicle Stimulating Hormone Production Value by Type (2019-2030)
5.3.3 World Recombinant Follicle Stimulating Hormone Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Recombinant Follicle Stimulating Hormone Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Infertility Treatment
6.2.2 Assisted Reproductive Technology
6.3 Market Segment by Application
6.3.1 World Recombinant Follicle Stimulating Hormone Production by Application (2019-2030)
6.3.2 World Recombinant Follicle Stimulating Hormone Production Value by Application (2019-2030)
6.3.3 World Recombinant Follicle Stimulating Hormone Average Price by Application (2019-2030)

7 Company Profiles
7.1 Merck Serono
7.1.1 Merck Serono Details
7.1.2 Merck Serono Major Business
7.1.3 Merck Serono Recombinant Follicle Stimulating Hormone Product and Services
7.1.4 Merck Serono Recombinant Follicle Stimulating Hormone Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Merck Serono Recent Developments/Updates
7.1.6 Merck Serono Competitive Strengths & Weaknesses
7.2 MSD
7.2.1 MSD Details
7.2.2 MSD Major Business
7.2.3 MSD Recombinant Follicle Stimulating Hormone Product and Services
7.2.4 MSD Recombinant Follicle Stimulating Hormone Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 MSD Recent Developments/Updates
7.2.6 MSD Competitive Strengths & Weaknesses
7.3 Techwell
7.3.1 Techwell Details
7.3.2 Techwell Major Business
7.3.3 Techwell Recombinant Follicle Stimulating Hormone Product and Services
7.3.4 Techwell Recombinant Follicle Stimulating Hormone Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Techwell Recent Developments/Updates
7.3.6 Techwell Competitive Strengths & Weaknesses
7.4 GenSci
7.4.1 GenSci Details
7.4.2 GenSci Major Business
7.4.3 GenSci Recombinant Follicle Stimulating Hormone Product and Services
7.4.4 GenSci Recombinant Follicle Stimulating Hormone Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 GenSci Recent Developments/Updates
7.4.6 GenSci Competitive Strengths & Weaknesses
7.5 Gedeon Richter
7.5.1 Gedeon Richter Details
7.5.2 Gedeon Richter Major Business
7.5.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Product and Services
7.5.4 Gedeon Richter Recombinant Follicle Stimulating Hormone Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Gedeon Richter Recent Developments/Updates
7.5.6 Gedeon Richter Competitive Strengths & Weaknesses
7.6 Teva
7.6.1 Teva Details
7.6.2 Teva Major Business
7.6.3 Teva Recombinant Follicle Stimulating Hormone Product and Services
7.6.4 Teva Recombinant Follicle Stimulating Hormone Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Teva Recent Developments/Updates
7.6.6 Teva Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Recombinant Follicle Stimulating Hormone Industry Chain
8.2 Recombinant Follicle Stimulating Hormone Upstream Analysis
8.2.1 Recombinant Follicle Stimulating Hormone Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Follicle Stimulating Hormone Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Follicle Stimulating Hormone Production Mode
8.6 Recombinant Follicle Stimulating Hormone Procurement Model
8.7 Recombinant Follicle Stimulating Hormone Industry Sales Model and Sales Channels
8.7.1 Recombinant Follicle Stimulating Hormone Sales Model
8.7.2 Recombinant Follicle Stimulating Hormone Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Recombinant Follicle Stimulating Hormone Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Recombinant Follicle Stimulating Hormone Production Value by Region (2019-2024) & (USD Million)
Table 3. World Recombinant Follicle Stimulating Hormone Production Value by Region (2025-2030) & (USD Million)
Table 4. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Region (2019-2024)
Table 5. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Region (2025-2030)
Table 6. World Recombinant Follicle Stimulating Hormone Production by Region (2019-2024) & (K Doses)
Table 7. World Recombinant Follicle Stimulating Hormone Production by Region (2025-2030) & (K Doses)
Table 8. World Recombinant Follicle Stimulating Hormone Production Market Share by Region (2019-2024)
Table 9. World Recombinant Follicle Stimulating Hormone Production Market Share by Region (2025-2030)
Table 10. World Recombinant Follicle Stimulating Hormone Average Price by Region (2019-2024) & (USD/Dose)
Table 11. World Recombinant Follicle Stimulating Hormone Average Price by Region (2025-2030) & (USD/Dose)
Table 12. Recombinant Follicle Stimulating Hormone Major Market Trends
Table 13. World Recombinant Follicle Stimulating Hormone Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Doses)
Table 14. World Recombinant Follicle Stimulating Hormone Consumption by Region (2019-2024) & (K Doses)
Table 15. World Recombinant Follicle Stimulating Hormone Consumption Forecast by Region (2025-2030) & (K Doses)
Table 16. World Recombinant Follicle Stimulating Hormone Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Follicle Stimulating Hormone Producers in 2023
Table 18. World Recombinant Follicle Stimulating Hormone Production by Manufacturer (2019-2024) & (K Doses)
Table 19. Production Market Share of Key Recombinant Follicle Stimulating Hormone Producers in 2023
Table 20. World Recombinant Follicle Stimulating Hormone Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 21. Global Recombinant Follicle Stimulating Hormone Company Evaluation Quadrant
Table 22. World Recombinant Follicle Stimulating Hormone Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Recombinant Follicle Stimulating Hormone Production Site of Key Manufacturer
Table 24. Recombinant Follicle Stimulating Hormone Market: Company Product Type Footprint
Table 25. Recombinant Follicle Stimulating Hormone Market: Company Product Application Footprint
Table 26. Recombinant Follicle Stimulating Hormone Competitive Factors
Table 27. Recombinant Follicle Stimulating Hormone New Entrant and Capacity Expansion Plans
Table 28. Recombinant Follicle Stimulating Hormone Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Follicle Stimulating Hormone Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Recombinant Follicle Stimulating Hormone Production Comparison, (2019 & 2023 & 2030) & (K Doses)
Table 31. United States VS China Recombinant Follicle Stimulating Hormone Consumption Comparison, (2019 & 2023 & 2030) & (K Doses)
Table 32. United States Based Recombinant Follicle Stimulating Hormone Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production (2019-2024) & (K Doses)
Table 36. United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production Market Share (2019-2024)
Table 37. China Based Recombinant Follicle Stimulating Hormone Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Recombinant Follicle Stimulating Hormone Production (2019-2024) & (K Doses)
Table 41. China Based Manufacturers Recombinant Follicle Stimulating Hormone Production Market Share (2019-2024)
Table 42. Rest of World Based Recombinant Follicle Stimulating Hormone Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production (2019-2024) & (K Doses)
Table 46. Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production Market Share (2019-2024)
Table 47. World Recombinant Follicle Stimulating Hormone Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Recombinant Follicle Stimulating Hormone Production by Type (2019-2024) & (K Doses)
Table 49. World Recombinant Follicle Stimulating Hormone Production by Type (2025-2030) & (K Doses)
Table 50. World Recombinant Follicle Stimulating Hormone Production Value by Type (2019-2024) & (USD Million)
Table 51. World Recombinant Follicle Stimulating Hormone Production Value by Type (2025-2030) & (USD Million)
Table 52. World Recombinant Follicle Stimulating Hormone Average Price by Type (2019-2024) & (USD/Dose)
Table 53. World Recombinant Follicle Stimulating Hormone Average Price by Type (2025-2030) & (USD/Dose)
Table 54. World Recombinant Follicle Stimulating Hormone Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Recombinant Follicle Stimulating Hormone Production by Application (2019-2024) & (K Doses)
Table 56. World Recombinant Follicle Stimulating Hormone Production by Application (2025-2030) & (K Doses)
Table 57. World Recombinant Follicle Stimulating Hormone Production Value by Application (2019-2024) & (USD Million)
Table 58. World Recombinant Follicle Stimulating Hormone Production Value by Application (2025-2030) & (USD Million)
Table 59. World Recombinant Follicle Stimulating Hormone Average Price by Application (2019-2024) & (USD/Dose)
Table 60. World Recombinant Follicle Stimulating Hormone Average Price by Application (2025-2030) & (USD/Dose)
Table 61. Merck Serono Basic Information, Manufacturing Base and Competitors
Table 62. Merck Serono Major Business
Table 63. Merck Serono Recombinant Follicle Stimulating Hormone Product and Services
Table 64. Merck Serono Recombinant Follicle Stimulating Hormone Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Merck Serono Recent Developments/Updates
Table 66. Merck Serono Competitive Strengths & Weaknesses
Table 67. MSD Basic Information, Manufacturing Base and Competitors
Table 68. MSD Major Business
Table 69. MSD Recombinant Follicle Stimulating Hormone Product and Services
Table 70. MSD Recombinant Follicle Stimulating Hormone Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. MSD Recent Developments/Updates
Table 72. MSD Competitive Strengths & Weaknesses
Table 73. Techwell Basic Information, Manufacturing Base and Competitors
Table 74. Techwell Major Business
Table 75. Techwell Recombinant Follicle Stimulating Hormone Product and Services
Table 76. Techwell Recombinant Follicle Stimulating Hormone Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Techwell Recent Developments/Updates
Table 78. Techwell Competitive Strengths & Weaknesses
Table 79. GenSci Basic Information, Manufacturing Base and Competitors
Table 80. GenSci Major Business
Table 81. GenSci Recombinant Follicle Stimulating Hormone Product and Services
Table 82. GenSci Recombinant Follicle Stimulating Hormone Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. GenSci Recent Developments/Updates
Table 84. GenSci Competitive Strengths & Weaknesses
Table 85. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 86. Gedeon Richter Major Business
Table 87. Gedeon Richter Recombinant Follicle Stimulating Hormone Product and Services
Table 88. Gedeon Richter Recombinant Follicle Stimulating Hormone Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Gedeon Richter Recent Developments/Updates
Table 90. Teva Basic Information, Manufacturing Base and Competitors
Table 91. Teva Major Business
Table 92. Teva Recombinant Follicle Stimulating Hormone Product and Services
Table 93. Teva Recombinant Follicle Stimulating Hormone Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Global Key Players of Recombinant Follicle Stimulating Hormone Upstream (Raw Materials)
Table 95. Recombinant Follicle Stimulating Hormone Typical Customers
Table 96. Recombinant Follicle Stimulating Hormone Typical Distributors
List of Figure
Figure 1. Recombinant Follicle Stimulating Hormone Picture
Figure 2. World Recombinant Follicle Stimulating Hormone Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Recombinant Follicle Stimulating Hormone Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Recombinant Follicle Stimulating Hormone Production (2019-2030) & (K Doses)
Figure 5. World Recombinant Follicle Stimulating Hormone Average Price (2019-2030) & (USD/Dose)
Figure 6. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Region (2019-2030)
Figure 7. World Recombinant Follicle Stimulating Hormone Production Market Share by Region (2019-2030)
Figure 8. North America Recombinant Follicle Stimulating Hormone Production (2019-2030) & (K Doses)
Figure 9. Europe Recombinant Follicle Stimulating Hormone Production (2019-2030) & (K Doses)
Figure 10. China Recombinant Follicle Stimulating Hormone Production (2019-2030) & (K Doses)
Figure 11. Japan Recombinant Follicle Stimulating Hormone Production (2019-2030) & (K Doses)
Figure 12. Recombinant Follicle Stimulating Hormone Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 15. World Recombinant Follicle Stimulating Hormone Consumption Market Share by Region (2019-2030)
Figure 16. United States Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 17. China Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 18. Europe Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 19. Japan Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 20. South Korea Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 21. ASEAN Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 22. India Recombinant Follicle Stimulating Hormone Consumption (2019-2030) & (K Doses)
Figure 23. Producer Shipments of Recombinant Follicle Stimulating Hormone by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Follicle Stimulating Hormone Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Follicle Stimulating Hormone Markets in 2023
Figure 26. United States VS China: Recombinant Follicle Stimulating Hormone Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Recombinant Follicle Stimulating Hormone Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Recombinant Follicle Stimulating Hormone Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Recombinant Follicle Stimulating Hormone Production Market Share 2023
Figure 30. China Based Manufacturers Recombinant Follicle Stimulating Hormone Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Recombinant Follicle Stimulating Hormone Production Market Share 2023
Figure 32. World Recombinant Follicle Stimulating Hormone Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Type in 2023
Figure 34. 75IU
Figure 35. 150IU
Figure 36. Others
Figure 37. World Recombinant Follicle Stimulating Hormone Production Market Share by Type (2019-2030)
Figure 38. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Type (2019-2030)
Figure 39. World Recombinant Follicle Stimulating Hormone Average Price by Type (2019-2030) & (USD/Dose)
Figure 40. World Recombinant Follicle Stimulating Hormone Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Application in 2023
Figure 42. Infertility Treatment
Figure 43. Assisted Reproductive Technology
Figure 44. World Recombinant Follicle Stimulating Hormone Production Market Share by Application (2019-2030)
Figure 45. World Recombinant Follicle Stimulating Hormone Production Value Market Share by Application (2019-2030)
Figure 46. World Recombinant Follicle Stimulating Hormone Average Price by Application (2019-2030) & (USD/Dose)
Figure 47. Recombinant Follicle Stimulating Hormone Industry Chain
Figure 48. Recombinant Follicle Stimulating Hormone Procurement Model
Figure 49. Recombinant Follicle Stimulating Hormone Sales Model
Figure 50. Recombinant Follicle Stimulating Hormone Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Merck Serono
MSD
Techwell
GenSci
Gedeon Richter
Teva
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now